Whitehawk Therapeutics (WHWK) Profit After Tax (2018 - 2025)
Historic Profit After Tax for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to -$17.7 million.
- Whitehawk Therapeutics' Profit After Tax fell 4144.75% to -$17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.6 million, marking a year-over-year increase of 7467.01%. This contributed to the annual value of -$63.7 million for FY2024, which is 314.0% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Profit After Tax is -$17.7 million, which was down 4144.75% from -$52.6 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Profit After Tax high stood at $73.0 million for Q1 2025, and its period low was -$87.1 million during Q3 2021.
- In the last 5 years, Whitehawk Therapeutics' Profit After Tax had a median value of -$16.0 million in 2021 and averaged -$15.7 million.
- Its Profit After Tax has fluctuated over the past 5 years, first tumbled by 291134.16% in 2021, then skyrocketed by 49899.45% in 2025.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Profit After Tax stood at -$16.0 million in 2021, then increased by 13.04% to -$13.9 million in 2022, then dropped by 16.91% to -$16.3 million in 2023, then dropped by 12.4% to -$18.3 million in 2024, then grew by 2.93% to -$17.7 million in 2025.
- Its Profit After Tax stands at -$17.7 million for Q3 2025, versus -$52.6 million for Q2 2025 and $73.0 million for Q1 2025.